A - Agilent Technologies - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Web URL: https://www.agilent.com
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
A Stock Overview
Market Cap in USD | 40,763m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 1999-11-18 |
A Stock Ratings
Growth 5y | 54.3 |
Fundamental | 79.2 |
Dividend | 28.3 |
Rel. Performance vs Sector | -0.73 |
Analysts | 3.65/5 |
Fair Price Momentum | 145.30 USD |
Fair Price DCF | 123.03 USD |
A Dividends
Dividend Yield 12m | 0.65% |
Yield on Cost 5y | 1.30% |
Dividends CAGR 5y | 6.27% |
Payout Consistency | 63.1% |
A Growth Ratios
Growth 12m | 31.92% |
Growth Correlation 12m | 56% |
Growth Correlation 3m | 74% |
CAGR 5y | 14.81% |
CAGR/Mean DD 5y | 0.92 |
Sharpe Ratio 12m | 0.98 |
Alpha vs SP500 12m | -0.19 |
Beta vs SP500 5y weekly | 0.90 |
ValueRay RSI | 72.23 |
Volatility GJR Garch 1y | 27.27% |
Price / SMA 50 | 3.7% |
Price / SMA 200 | 5.31% |
Current Volume | 1001.1k |
Average Volume 20d | 1521.1k |
External Links for A Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of A stocks?
As of October 05, 2024, the stock is trading at USD 144.97 with a total of 1,001,100 shares traded.
Over the past week, the price has changed by -1.93%, over one month by +5.10%, over three months by +14.90% and over the past year by +31.16%.
As of October 05, 2024, the stock is trading at USD 144.97 with a total of 1,001,100 shares traded.
Over the past week, the price has changed by -1.93%, over one month by +5.10%, over three months by +14.90% and over the past year by +31.16%.
What are the forecast for A stock price target?
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 160.1 in October 2025. The stock is currently trading at 144.97. This means that the stock has a potential upside of +10.46%.
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 160.1 in October 2025. The stock is currently trading at 144.97. This means that the stock has a potential upside of +10.46%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 146 | 0.74 |
Analysts Target Price | 135.8 | -6.36 |
ValueRay Target Price | 160.1 | 10.5 |